Skip to main content

Table 4 Patient characteristics and outcomes in iGAS patients without or with emm1/T1. Values are median (Q1–Q3) or number (%)

From: Morbidity and mortality in critically ill patients with invasive group A streptococcus infection: an observational study

 

iGAS without emm1/T1, n = 25

iGAS with emm1/T1, n = 25

p valuea

Origin of infection

 Soft tissue

11 (44)

18 (72)

0.08

 Necrotizing fasciitis

7 (28)

12 (48)

0.24

 Pneumonia

3 (12)

3 (12)

1.00

 Puerperal

2 (8.0)

0

0.49

 Arthritis

4 (16)

0

0.11

 Pharyngeal/parapharyngeal

1 (4.0)

2 (8.0)

1.00

 Mastoiditis

1 (4.0)

0

1.00

 Meningitis

0

1 (4.0)

1.00

 Unknown focus

3 (12)

1 (4.0)

0.61

Septic shock (Sepsis 3)b

11 (44)

10 (40)

1.00

IVIGc

7 (28)

13 (52)

0.15

DAFd vasopressor

26 (25–28)

25 (23–26)

0.036*

DAFd ventilation

26 (20–28)

24 (20–26)

0.23

CRRTe

4 (16)

8 (32)

0.32

AKIN-creaf

0 (0–3)

3 (0–3)

0.007*

SOFA maxg

9 (6–13)

12 (7–14)

0.11

Length of stay, survivors

2.7 (1.2–4.7)

5.1 (2.3–7.5)

0.08

SAPS 3h

65 (54–70)

61 (58–78)

0.27

EMRi

28 (11–39)

21 (15–54)

0.27

ICUj mortality

2 (8.0)

1 (4.0)

1.00

28-day mortality

5 (20)

1 (4.0)

0.19

90-day mortality

6 (24)

2 (8.0)

0.25

180-day mortality

8 (32)

3 (12)

0.17

  1. aFisher’s exact test or Mann-Whitney, *p ≤ 0.05
  2. bAll patients included in the study were diagnosed with severe sepsis or septic shock according to Sepsis 2 definition. Patients in the iGAS group were also described as having septic shock (Sepsis 3) or not
  3. cIntravenous immunoglobulin
  4. dDays alive and free
  5. eContinuous renal replacement therapy
  6. fMaximum Acute Kidney Injury Network classification score the first 10 days after admission
  7. gMaximum Sequential Organ Failure Assessment score during ICU admission
  8. hSimplified Acute Physiology Score 3
  9. iEstimated mortality rate
  10. jIntensive care unit